Citizens Maintains Market Outperform on Zimmer Biomet Holdings, Lowers Price Target to $105

Citizens analyst David Turkaly maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Market Outperform and lowers the price target from $120 to $105.